Pediatrix Medical Group (MD) Competitors $14.09 -0.16 (-1.12%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends MD vs. AMED, AMN, CCRN, LH, DGX, DVA, CHE, CRVL, RCM, and SEMShould you be buying Pediatrix Medical Group stock or one of its competitors? The main competitors of Pediatrix Medical Group include Amedisys (AMED), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), CorVel (CRVL), R1 RCM (RCM), and Select Medical (SEM). Pediatrix Medical Group vs. Amedisys AMN Healthcare Services Cross Country Healthcare Laboratory Co. of America Quest Diagnostics DaVita Chemed CorVel R1 RCM Select Medical Amedisys (NASDAQ:AMED) and Pediatrix Medical Group (NYSE:MD) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, media sentiment, valuation, dividends, community ranking and profitability. Do analysts recommend AMED or MD? Amedisys currently has a consensus target price of $100.67, indicating a potential upside of 19.17%. Pediatrix Medical Group has a consensus target price of $16.42, indicating a potential upside of 16.51%. Given Amedisys' higher possible upside, analysts clearly believe Amedisys is more favorable than Pediatrix Medical Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Amedisys 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.20Pediatrix Medical Group 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Which has more risk and volatility, AMED or MD? Amedisys has a beta of 0.73, indicating that its share price is 27% less volatile than the S&P 500. Comparatively, Pediatrix Medical Group has a beta of 1.57, indicating that its share price is 57% more volatile than the S&P 500. Is AMED or MD more profitable? Amedisys has a net margin of 3.57% compared to Pediatrix Medical Group's net margin of -12.65%. Pediatrix Medical Group's return on equity of 12.79% beat Amedisys' return on equity.Company Net Margins Return on Equity Return on Assets Amedisys3.57% 12.20% 6.74% Pediatrix Medical Group -12.65%12.79%4.75% Does the MarketBeat Community favor AMED or MD? Pediatrix Medical Group received 10 more outperform votes than Amedisys when rated by MarketBeat users. Likewise, 60.33% of users gave Pediatrix Medical Group an outperform vote while only 58.72% of users gave Amedisys an outperform vote. CompanyUnderperformOutperformAmedisysOutperform Votes49558.72% Underperform Votes34841.28% Pediatrix Medical GroupOutperform Votes50560.33% Underperform Votes33239.67% Which has higher valuation and earnings, AMED or MD? Amedisys has higher revenue and earnings than Pediatrix Medical Group. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than Amedisys, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmedisys$2.32B1.19-$9.75M$2.5233.52Pediatrix Medical Group$2.01B0.60-$60.41M-$3.06-4.60 Does the media favor AMED or MD? In the previous week, Pediatrix Medical Group had 7 more articles in the media than Amedisys. MarketBeat recorded 9 mentions for Pediatrix Medical Group and 2 mentions for Amedisys. Amedisys' average media sentiment score of 1.00 beat Pediatrix Medical Group's score of 0.53 indicating that Amedisys is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amedisys 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Pediatrix Medical Group 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders have more ownership in AMED or MD? 94.4% of Amedisys shares are held by institutional investors. Comparatively, 97.7% of Pediatrix Medical Group shares are held by institutional investors. 2.1% of Amedisys shares are held by company insiders. Comparatively, 2.0% of Pediatrix Medical Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryAmedisys beats Pediatrix Medical Group on 10 of the 18 factors compared between the two stocks. Ad Porter & CompanyAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.I urge you to watch it now. Get Pediatrix Medical Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MD vs. The Competition Export to ExcelMetricPediatrix Medical GroupHospitals IndustryMedical SectorNYSE ExchangeMarket Cap$1.21B$4.40B$5.14B$19.19BDividend YieldN/A1.64%5.09%3.61%P/E Ratio-4.6010.5789.8241.30Price / Sales0.600.931,116.2117.58Price / Cash8.979.9842.8921.28Price / Book1.402.394.785.32Net Income-$60.41M$178.36M$120.23M$989.88M7 Day Performance0.14%-1.94%-1.92%-3.54%1 Month Performance-4.47%-20.01%11.49%-3.68%1 Year Performance49.42%23.64%30.57%12.14% Pediatrix Medical Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDPediatrix Medical Group3.2291 of 5 stars$14.09-1.1%$16.42+16.5%+57.3%$1.21B$2.01B-4.605,170Analyst DowngradeNews CoverageHigh Trading VolumeAMEDAmedisys3.9465 of 5 stars$85.92+0.3%$100.67+17.2%-11.1%$2.81B$2.32B33.9719,000Positive NewsAMNAMN Healthcare Services4.7616 of 5 stars$25.67-5.0%$48.33+88.3%-67.5%$977.36M$3.07B19.583,585CCRNCross Country Healthcare3.1144 of 5 stars$17.97-0.5%$18.54+3.2%-18.6%$591.52M$1.45B-359.4010,831LHLaboratory Co. of America4.9653 of 5 stars$231.01-0.4%$257.67+11.5%+3.8%$19.32B$12.71B44.8867,000Analyst ForecastPositive NewsDGXQuest Diagnostics4.9424 of 5 stars$154.32-0.4%$168.92+9.5%+13.6%$17.22B$9.54B20.8348,000Analyst UpgradeDVADaVita4.2664 of 5 stars$152.43-0.2%$161.80+6.1%+46.2%$12.50B$12.14B16.4870,000CHEChemed4.9269 of 5 stars$544.08-0.5%$641.50+17.9%-10.1%$8.19B$2.38B27.6415,087Positive NewsCRVLCorVel1.1283 of 5 stars$361.80+2.8%N/A+43.9%$6.20B$845.64M74.734,870Stock SplitPositive NewsGap DownRCMR1 RCM1.1634 of 5 stars$14.31+0.1%$15.73+9.9%+42.0%$6.04B$2.25B-95.3930,000High Trading VolumeSEMSelect Medical4.9682 of 5 stars$19.91+2.2%$45.67+129.4%-19.7%$2.58B$6.66B9.1054,600Positive News Related Companies and Tools Related Companies AMED Competitors AMN Competitors CCRN Competitors LH Competitors DGX Competitors DVA Competitors CHE Competitors CRVL Competitors RCM Competitors SEM Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:MD) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pediatrix Medical Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pediatrix Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
